Research Alliance Corporation III – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

Prospectuses and Registrations Filter

Business combination disclosure

Business combination disclosure

Details of business combination or exchange offer

Business combination disclosure

Business combination disclosure

Ownership Filter

Great Point Partners LLC

TCG Crossover GP III, LLC

Balyasny Asset Management L.P.

ADAR1 Capital Management, LLC

Spruce Street Capital LP

News Filter

Oak Hill Bio and Research Alliance Corporation III Announce Business Combination Agreement to Create Publicly Listed Rare Disease Biotechnology Company to Advance Antisense Oligonucleotide Therapy Rugonersen for Angelman Syndrome

Index to Financial Statement

Announces Pricing of $75 Million Initial Public Offering

Proxies

No filings in this category.

Other Filter

Notice of effectiveness